Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy of SYR-322 With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes Mellitus
This study has been completed.
Study NCT00395512   Information provided by Takeda Global Research & Development Center, Inc.
First Received: November 1, 2006   Last Updated: July 30, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus
Additional conditions recognized in this trial
Diabetes Mellitus, Type 2
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
SYR-322 and pioglitazone
SYR-322
Pioglitazone
More general drug interventions related to this trial
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Takeda Global Research &Development Center, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services